ATHE: Alterity Therapeutics Limited – Depositary Receipt (Common Stock) Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 17.62
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 17.42
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.45
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 4.90
Current Ratio 4.90

Balance Sheet (mrq) ($M)
Current Assets 21.99
Assets 22.19
Liabilities 4.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 77,006 167,614 45.94
2024-04-23 10,617 29,994 35.40
2024-04-22 9,233 4,893 188.70
2024-04-19 13,513 7,389 182.88

(click for more detail)

Similar Companies
AADI – Aadi Bioscience, Inc. ABEO – Abeona Therapeutics Inc.
ABIO – ARCA biopharma, Inc. ABVC – ABVC BioPharma, Inc.
ACB – Aurora Cannabis Inc.


Financial data and stock pages provided by
Fintel.io